People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Technology, Business Services, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mevion Medical Systems, Inc. | — | Biotechnology | Series C | $95.3M | $2.4B | 2011 |
| InSitu Biologics, Inc | — | Biotechnology | Series A | $13.9M | $10.7M | 2020 |
| Immune Therapeutics, Inc. | — | Biotechnology | Series A | $8.5M | $63.5M | 2022 |
| NEOSYSTEMS Corp | — | Other Technology | Series A | $5.5M | $152.6M | 2014 |
| TechPubs, Inc. | — | Other Technology | Seed | $5.3M | $114.8M | 2011 |
| Arya, Inc. | — | Business Services | Seed | $3.3M | $4.5M | 2024 |
| Neural Therapeutics Inc. | — | Pharma | Pre-Seed | $591K | $11.0M | 2022 |
Robert Wilson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Wilson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Williams | 1 | 17 |
| Buzz Benson | 1 | 8 |
| Ian Campbell | 1 | 6 |
| Mitchell Bloom | 1 | 6 |
| Myles Greenberg | 1 | 6 |
| Kenneth Gall | 1 | 5 |
| Kevin Barrett | 1 | 5 |
| Kevin Phelps | 1 | 4 |
| Anders Hove | 1 | 4 |
| Jay Moorin | 1 | 4 |
| James Knapp | 1 | 3 |
| Marc Buntaine | 1 | 3 |
| Seth Elliott | 1 | 3 |
| Stephen Wilson | 1 | 3 |
| Kevin Bassett | 1 | 2 |
| Cheng Lu | 1 | 2 |
| PETER ARONSTAM | 1 | 2 |
| Robert F. Agnew | 1 | 2 |
| Vincent Butta | 1 | 2 |
| Roscoe Moore | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.